Magnetic resonance-guided focused ultrasound therapy (ExAblate 2000; InSightec Ltd.) for ablation of uterine fibroids
HAYES, Inc.
Record ID 32017000040
English
Authors' objectives:
Description of Technology: Magnetic resonance–guided focused ultrasound (MRgFUS) combines thermal effects (due to absorption of acoustic energy) with magnetic resonance imaging to treat symptomatic uterine fibroids. Thermal ablation by MRgFUS causes cell death and coagulative necrosis of the targeted tissue while sparing surrounding organs. MRgFUS ablation of uterine fibroids is performed by a board-certified interventional radiologist on an outpatient basis.
Patient Population: MRgFUS is indicated to ablate uterine fibroid tissue in premenopausal or perimenopausal women with symptomatic uterine fibroids who desire a uterine-sparing procedure and whose uterine size is less than 24 weeks gestation size.
Details
Project Status:
Completed
Year Published:
2016
URL for published report:
The report may be purchased from:
http://www.hayesinc.com/hayes/crd/?crd=1006
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Humans
- Female
- Leiomyoma
- Magnetic Resonance Spectroscopy
- Uterine Neoplasms
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2014 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.